Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Limosilactobacillus reuteri {L. Reuteri} - Staphylococcus |
👪
Exopolysaccharides from camel milk-derived Limosilactobacillus reuteri C66: Structural characterization, bioactive and rheological properties for food applications. Food chemistry: X (Food Chem X ) Vol: 25 Issue Pages: 102164 Pub: 2025 Jan Epub: 2025 Jan 27 Authors Kober AKMH , Abdin M , Subhash A , Liu SQ , Dertli E , Abu-Jdayil B , Show PL , Ayyash M , Html Article Publication |
| Limosilactobacillus reuteri {L. Reuteri} - Staphylococcus |
📓
Antimicrobial Properties of a Potential Probiotic Lactobacillus from Thai Newborn Feces. Journal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai ) Vol: 98 Suppl 9 Issue Pages: S116-22 Pub: 2015 Oct Epub: Authors Chimchang J , Theparee T , Ladda B , Tanasupawat S , Wongsatayanon BT , Taweechotipatr M , |
| Limosilactobacillus reuteri {L. Reuteri} - Staphylococcus |
📓
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , Publication Publication |
| Limosilactobacillus reuteri {L. Reuteri} - Staphylococcus |
👪
Lactobacillus reuteri inhibits Staphylococcus aureus-induced mastitis by regulating oxytocin releasing and gut microbiota in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J ) Vol: 38 Issue 2 Pages: e23383 Pub: 2024 Jan 31 Epub: Authors He Z , Li W , Yuan W , He Y , Xu J , Yuan C , Zhao C , Zhang N , Fu Y , Hu X , Publication |
| Limosilactobacillus reuteri {L. Reuteri} - Staphylococcus |
👪
Effect of Lactobacillus reuteri on the proliferation of Propionibacterium acnes and Staphylococcus epidermidis. Journal of microbiology (Seoul, Korea) (J Microbiol ) Vol: 50 Issue 1 Pages: 137-42 Pub: 2012 Feb Epub: 2012 Feb 27 Authors Kang MS , Oh JS , Lee SW , Lim HS , Choi NK , Kim SM , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
